Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
This report elaborates on the current development of the Immunology Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
GlaxoSmithKline plc
Bayer AG
Seattle Genetics
Eli Lilly and Company
Active Biotech
Genentech
Abbott Laboratories
By Type:
Interferon and Cytokine therapies
Immunosuppressive medication
Antibody Drug Conjugates
Monoclonal Antibodies (mAb)
By Application:
Clinics
Hospitals
Cancer Research Centers and Institutes
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Immunology Drug Market Overview 2018-2029
-
1.1 China Immunology Drug Industry Development Overview
-
1.2 China Immunology Drug Industry Development History
-
1.3 China Immunology Drug Industry Market Size (2018-2029)
-
1.4 China Immunology Drug Market Analysis by Type from Production Side
-
1.4.1 China Immunology Drug Production Volume, Production Value and Growth Rate of Interferon and Cytokine therapies (2018-2029)
-
1.4.2 China Immunology Drug Production Volume, Production Value and Growth Rate of Immunosuppressive medication (2018-2029)
-
1.4.3 China Immunology Drug Production Volume, Production Value and Growth Rate of Antibody Drug Conjugates (2018-2029)
-
1.4.4 China Immunology Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (mAb) (2018-2029)
-
1.5 China Immunology Drug Market Analysis by Application from Consumption End
-
1.5.1 China Immunology Drug Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
1.5.2 China Immunology Drug Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.3 China Immunology Drug Sales Volume, Sales Value and Growth Rate of Cancer Research Centers and Institutes (2018-2029)
-
1.6 China Immunology Drug Market Analysis by Region
-
1.6.1 North China Immunology Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Immunology Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Immunology Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Immunology Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Immunology Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Immunology Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Immunology Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Immunology Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Immunology Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Immunology Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Immunology Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Immunology Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Immunology Drug Industry Development
Chapter 3 Immunology DrugIndustry Chain Analysis
-
3.1 Immunology Drug Industry Chain
-
3.2 Immunology Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Immunology Drug Market
-
3.3 Immunology Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Immunology Drug Market
Chapter 4 China Immunology Drug Market, by Type
-
4.1 China Immunology Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Immunology Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Immunology Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Immunology Drug Production Volume and Growth Rate of Interferon and Cytokine therapies
-
4.5.2 China Immunology Drug Production Volume and Growth Rate of Immunosuppressive medication
-
4.5.3 China Immunology Drug Production Volume and Growth Rate of Antibody Drug Conjugates
-
4.5.4 China Immunology Drug Production Volume and Growth Rate of Monoclonal Antibodies (mAb)
Chapter 5 China Immunology Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Immunology Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Immunology Drug Market Size and Growth Rate, by Application
-
5.5.1 China Immunology Drug Market Size and Growth Rate of Clinics
-
5.5.2 China Immunology Drug Market Size and Growth Rate of Hospitals
-
5.5.3 China Immunology Drug Market Size and Growth Rate of Cancer Research Centers and Institutes
Chapter 6 China Immunology Drug Market, by Region
-
6.1 China Immunology Drug Production Volume and Production Value, by Region
-
6.2 China Immunology Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Immunology Drug Market Analysis
-
7.1 North China Immunology Drug Market, by Type
-
7.2 North China Immunology Drug Market, by Application
Chapter 8 Central China Immunology Drug Market Analysis
-
8.1 Central China Immunology Drug Market, by Type
-
8.2 Central China Immunology Drug Market, by Application
Chapter 9 South China Immunology Drug Market Analysis
-
9.1 South China Immunology Drug Market, by Type
-
9.2 South China Immunology Drug Market, by Application
Chapter 10 East China Immunology Drug Market Analysis
-
10.1 East China Immunology Drug Market, by Type
-
10.2 East China Immunology Drug Market, by Application
Chapter 11 Northeast China Immunology Drug Market Analysis
-
11.1 Northeast China Immunology Drug Market, by Type
-
11.2 Northeast China Immunology Drug Market, by Application
Chapter 12 Southwest China Immunology Drug Market Analysis
-
12.1 Southwest China Immunology Drug Market, by Type
-
12.2 Southwest China Immunology Drug Market, by Application
Chapter 13 Northwest China Immunology Drug Market Analysis
-
13.1 Northwest China Immunology Drug Market, by Type
-
13.2 Northwest China Immunology Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 GlaxoSmithKline plc
-
14.1.1 GlaxoSmithKline plc Company Profile
-
14.1.2 GlaxoSmithKline plc Immunology Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Bayer AG
-
14.2.1 Bayer AG Company Profile
-
14.2.2 Bayer AG Immunology Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Seattle Genetics
-
14.3.1 Seattle Genetics Company Profile
-
14.3.2 Seattle Genetics Immunology Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Eli Lilly and Company
-
14.4.1 Eli Lilly and Company Company Profile
-
14.4.2 Eli Lilly and Company Immunology Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Active Biotech
-
14.5.1 Active Biotech Company Profile
-
14.5.2 Active Biotech Immunology Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Genentech
-
14.6.1 Genentech Company Profile
-
14.6.2 Genentech Immunology Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Abbott Laboratories
-
14.7.1 Abbott Laboratories Company Profile
-
14.7.2 Abbott Laboratories Immunology Drug Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Immunology Drug Industry Research Conclusions
-
15.2 Immunology Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Immunology Drug Industry Market Size (2018-2029)
-
Figure China Immunology Drug Production Volume, Production Value and Growth Rate of Interferon and Cytokine therapies (2018-2029)
-
Figure China Immunology Drug Production Volume, Production Value and Growth Rate of Immunosuppressive medication (2018-2029)
-
Figure China Immunology Drug Production Volume, Production Value and Growth Rate of Antibody Drug Conjugates (2018-2029)
-
Figure China Immunology Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (mAb) (2018-2029)
-
Figure China Immunology Drug Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
Figure China Immunology Drug Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Immunology Drug Sales Volume, Sales Value and Growth Rate of Cancer Research Centers and Institutes (2018-2029)
-
Figure North China Immunology Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Immunology Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Immunology Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Immunology Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Immunology Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Immunology Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Immunology Drug Market Size and Growth Rate from 2018-2029
-
Figure Immunology Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Immunology Drug Market Share by Type in 2018
-
Figure China Immunology Drug Market Share by Type in 2023
-
Figure China Immunology Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Immunology Drug Production Volume and Growth Rate of Interferon and Cytokine therapies (2018-2023)
-
Figure China Immunology Drug Production Volume and Growth Rate of Immunosuppressive medication (2018-2023)
-
Figure China Immunology Drug Production Volume and Growth Rate of Antibody Drug Conjugates (2018-2023)
-
Figure China Immunology Drug Production Volume and Growth Rate of Monoclonal Antibodies (mAb) (2018-2023)
-
Figure China Immunology Drug Market Share by Application in 2018
-
Figure China Immunology Drug Market Share by Application in 2023
-
Figure China Immunology Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Immunology Drug Market Size and Growth Rate of Clinics (2018-2023)
-
Figure China Immunology Drug Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Immunology Drug Market Size and Growth Rate of Cancer Research Centers and Institutes (2018-2023)
-
Table China Immunology Drug Production Volume by Region (2018-2023)
-
Table China Immunology Drug Production Volume Share by Region (2018-2023)
-
Figure China Immunology Drug Production Volume Share by Region (2018-2023)
-
Table China Immunology Drug Production Value by Region (2018-2023)
-
Table China Immunology Drug Production Value Share by Region (2018-2023)
-
Figure China Immunology Drug Production Value Share by Region (2018-2023)
-
Table China Immunology Drug Sales Volume by Region (2018-2023)
-
Table China Immunology Drug Sales Volume Share by Region (2018-2023)
-
Figure China Immunology Drug Sales Volume Share by Region (2018-2023)
-
Table China Immunology Drug Sales Value by Region (2018-2023)
-
Table China Immunology Drug Sales Value Share by Region (2018-2023)
-
Figure China Immunology Drug Sales Value Share by Region (2018-2023)
-
Table North China Immunology Drug Production Volume by Type (2018-2023)
-
Table North China Immunology Drug Production Volume Share by Type (2018-2023)
-
Figure North China Immunology Drug Production Volume Share by Type (2018-2023)
-
Table North China Immunology Drug Sales Volume by Application (2018-2023)
-
Table North China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Immunology Drug Production Volume by Type (2018-2023)
-
Table Central China Immunology Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Immunology Drug Production Volume Share by Type (2018-2023)
-
Table Central China Immunology Drug Sales Volume by Application (2018-2023)
-
Table Central China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Table South China Immunology Drug Production Volume by Type (2018-2023)
-
Table South China Immunology Drug Production Volume Share by Type (2018-2023)
-
Figure South China Immunology Drug Production Volume Share by Type (2018-2023)
-
Table South China Immunology Drug Sales Volume by Application (2018-2023)
-
Table South China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Table East China Immunology Drug Production Volume by Type (2018-2023)
-
Table East China Immunology Drug Production Volume Share by Type (2018-2023)
-
Figure East China Immunology Drug Production Volume Share by Type (2018-2023)
-
Table East China Immunology Drug Sales Volume by Application (2018-2023)
-
Table East China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Immunology Drug Production Volume by Type (2018-2023)
-
Table Northeast China Immunology Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Immunology Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Immunology Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Immunology Drug Production Volume by Type (2018-2023)
-
Table Southwest China Immunology Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Immunology Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Immunology Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Immunology Drug Production Volume by Type (2018-2023)
-
Table Northwest China Immunology Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Immunology Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Immunology Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Immunology Drug Sales Volume Share by Application (2018-2023)
-
Table GlaxoSmithKline plc Company Profile
-
Table GlaxoSmithKline plc Immunology Drug Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Immunology Drug Revenue, Price and Gross (2018-2023)
-
Table Seattle Genetics Company Profile
-
Table Seattle Genetics Immunology Drug Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Immunology Drug Revenue, Price and Gross (2018-2023)
-
Table Active Biotech Company Profile
-
Table Active Biotech Immunology Drug Revenue, Price and Gross (2018-2023)
-
Table Genentech Company Profile
-
Table Genentech Immunology Drug Revenue, Price and Gross (2018-2023)
-
Table Abbott Laboratories Company Profile
-
Table Abbott Laboratories Immunology Drug Revenue, Price and Gross (2018-2023)
-
